(120 days)
Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. Atlantis® suprastructures are compatible with following implants and abutments: (list of compatible implants and abutments follows in the document)
Atlantis suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. The subject Atlantis suprastructures include new compatible interfaces of the currently marketed Atlantis suprastructures made by milling (K163350) or additive manufacturing techniques (K163398) for the following abutments and implants: (list of compatible implants and abutments follows in the document). The design of the subject device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the Atlantis suprastructures are fabricated using additive manufacturing (AM) to produce a customized, patient-specific device. The Atlantis suprastructures subject of this bundled premarket notification are fabricated by milling or by additive manufacturing techniques.
The milled Atlantis suprastructures are composed of commercially pure titanium (CPTi) or cobalt chrome alloy and are available in following design types: Bar, Bridge, Hybrid and 2 in 1. Additional design limitations regarding minimum required segment cross-section, maximum span between implants and maximum cantilever extension, have been introduced for Atlantis suprastructures made by milling.
Atlantis suprastructures made by additive manufacturing are provided as Bridge and Hybrid types with optional mechanical retention (pin or cell retention) on the surface. The manufacturing of the Bridges and Hybrids of the Atlantis suprastructures by an additive manufacturing technique start from a titanium alloy and a cobalt-chrome alloy in powder form.
Milled variants of the subject Atlantis® suprastructures are offered in versions composed of unalloyed titanium conforming to ASTM F67 (Standard Specification for Unalloyed Titanium for Surgical Implant Applications) and cobalt chromium alloy (CoCr) conforming to ISO 22674 (Dentistry – Metallic materials for fixed and removable restorations and appliances). Variants of the subject Atlantis® suprastructures which are fabricated utilizing additive manufacturing are manufactured using titanium alloy powder or cobalt chromium alloy powder conforming to ISO 22674 (Dentistrv – Metallic materials for fixed and removable restorations and appliances).
Fixation screws for use with the subject Atlantis® suprastructures are composed of titanium alloy confirming to ASTM F136 (Standard Specification for Wrought Titanium-6 Aluminum-4 Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications).
Screws are available for all compatible implants and abutments to screw the Atlantis suprastructures into the implant or onto the abutment.
Labeling is modified by providing a separate compatibility chart which lists all implants and abutments compatible with the Atlantis suprastructures.
This FDA 510(k) summary for the Dentsply Sirona Atlantis® suprastructures does not describe a clinical study for acceptance criteria. Instead, it argues for substantial equivalence to existing predicate devices based on non-clinical performance data and a comparison of indications for use, design, manufacturing techniques, and materials.
Here's an analysis of the provided information, addressing your points where possible:
1. Table of Acceptance Criteria and Reported Device Performance:
The document primarily relies on the equivalency to previously cleared devices. Therefore, explicit "acceptance criteria" in the sense of predefined thresholds for a new study are not presented. Instead, the performance is demonstrated through comparisons to the predicate devices and by referencing a previous fatigue test.
| Feature/Test | Acceptance Criteria (Implicit) | Reported Device Performance |
|---|---|---|
| Indications for Use | Identical clinical indications to predicate devices (K1633350, K163398) | Met by comparison: The clinical indications for use are identical to the predicate devices, differing only in the expanded list of compatible implants and abutments. (Text on page 9 "The indications for use of the subject and predicate Atlantis suprastructures (K163350, K163398) are identical with respect to the clinical indications.") |
| Compatible Interfaces (New) | Maintain structural integrity and performance when attached to new compatible implants/abutments. | Met by non-clinical testing and comparison: Cross-sectional material analysis of interfaces, geometric measurement data, and statistical compatibility analysis of OEM components support compatibility. Reference to results of fatigue testing (K160207) conducted according to ISO 14801. (Text on page 10 "Cross-sectional material analysis of the subject Atlantis suprastructure interfaces with the compatible implants and abutments, comparison to existing worst case interface geometry and reference to results of fatigue testing (K160207) conducted according to test methods of ISO 14801...") |
| Manufacturing Process (Additive Manufacturing) | Additive manufacturing process must be validated and ensure comparable device characteristics. | Met by reference to previous validation: Reference to process validation testing (K163398) for Atlantis suprastructures made by additive manufacturing. (Text on page 10) |
| Sterilization Parameters | Sterilization process must be validated according to relevant international standards. | Met by reference to previous validation: Reference by equivalence to validation of moist heat sterilization parameters conducted according to ISO 17665-1 and ISO 17665-2. (Text on page 10) |
| Biocompatibility | Device materials must be biocompatible. | Met by reference to previous data: Reference by equivalence to biocompatibility data of predicate devices (K163350, K163398). (Text on page 10) |
| Design Parameters (Milled) | Adherence to established design limitations for segment cross-section, span, and cantilever. | Met by comparison: Additional design limitations for some types of milled Atlantis suprastructures are within the design parameters cleared for the predicate device (K163350). (Text on page 10) |
| Design Parameters (Additive Manufacturing) | Adherence to established design parameters. | Met by comparison: The design parameters cleared for the predicate Atlantis suprastructures made by additive manufacturing (K163398) remain unchanged. (Text on page 10) |
| Materials | Conformity to specified ASTM and ISO standards for unalloyed titanium, titanium alloy, and cobalt-chrome alloy. | Met by specification: Milled variants composed of CPTi (ASTM F67) or CoCr (ISO 22674). Additive manufactured variants use titanium alloy powder or CoCr alloy powder (ISO 22674). Fixation screws are titanium alloy (ASTM F136). (Text on page 7) |
2. Sample Size Used for the Test Set and Data Provenance:
The document mentions "cross-sectional material analysis" and "geometric measurement data and statistical compatibility analysis." However, it does not provide specific sample sizes for these analyses. The data provenance is implied to be internal testing conducted by Dentsply Sirona or its subsidiaries, and it's non-clinical. There is no mention of country of origin for this testing data.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:
Not applicable. This device's clearance is based on non-clinical engineering and material testing, and substantial equivalence to existing devices, not a clinical study requiring expert ground truth for interpretation of outcomes.
4. Adjudication Method for the Test Set:
Not applicable, as no clinical test set requiring adjudication by experts is described.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
No. This is a dental implant suprastructure, not an imaging AI device where MRMC studies are typically performed.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:
No, this is a physical medical device. The "algorithm" aspect refers to the CAD design process, but the testing focuses on the resulting physical product's performance and compatibility, not an AI algorithm's diagnostic performance.
7. The Type of Ground Truth Used:
For the evaluation of the new compatible interfaces and materials, the "ground truth" is defined by:
- Engineering specifications and dimensional accuracy.
- Material property standards (ASTM F67, F136, ISO 22674).
- Performance standards, particularly ISO 14801 for fatigue testing.
- Comparison to the established performance of the predicate devices.
8. The Sample Size for the Training Set:
Not applicable. There is no mention of a training set for an AI algorithm. The CAD design uses pre-programmed libraries and patient-specific scans, but "training set" in the context of machine learning is not relevant here.
9. How the Ground Truth for the Training Set Was Established:
Not applicable, as there is no "training set" in the machine learning sense described for this device. The design process is CAD-based, utilizing established engineering principles and material science.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA text logo on the right. The text logo has the FDA acronym in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
March 3, 2020
Dentsply Sirona Inc. Karl Nittinger Vice President Corporate Regulatory Affairs 221 West Philadelphia Street, Suite 60W York, Pennsylvania 17401
Re: K193064
Trade/Device Name: Atlantis® suprastructures Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: December 3, 2019 Received: December 4, 2019
Dear Karl Nittinger:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
for Srinivas Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K193064
Device Name
Atlantis® suprastructures
Indications for Use (Describe)
Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function.
Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. Atlantis® suprastructures are compatible with following implants and abutments:
| Manufacturer/ | Implant system |
|---|---|
| BioHorizons | Implant LevelInternal/ Tapered 3.5, 4.5, 5.7Abutment LevelMulti-unit abutment |
| Biomet 3i | Implant LevelCertain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5Certain™ XP 4/5, 5/6Abutment LevelLow Profile Abutment |
| Camlog | Implant LevelScrew-line Implant 3.3Screw-line/Root-line Implant 3.8, 4.3Screw-line/Root-line Implant 5.0, 6.0 |
| DentsplySirona | Implant LevelAstra Tech Implant System®Astra Tech Implant EV 3.0 – GreenAstra Tech Implant EV 3.6 – PurpleAstra Tech Implant EV 4.2 – YellowAstra Tech Implant EV 4.8 – BlueAstra Tech Implant EV 5.4 – BrownAstra Tech Implant EV Profile 4.2Astra Tech Implant EV Profile 4.8OsseoSpeed® TX 3.0 – YellowOsseoSpeed® TX 3.5, 4.0 – AquaOsseoSpeed® TX 4.5, 5.0 – LilacOsseoSpeed® TX Profile 4.5/5.0Xive®Xive® S 3.0Xive® S 3.4, 3.8, 4.5, 5.5Abutment LevelAstra Tech Implant System®UniAbutment EVAngled Abutment EVMultibase Abutment EV20° UniAbutment45° Uni AbutmentAngled Abutment 20°Ankylos®Ankylos® Balance Base Narrow D4.2Ankylos® Balance Base D5.5 |
| Xive® | |
| Xive® TG 3.4, 3.8, 4.5 | |
| Xive® MP 3.4, 3.8, 4.5 | |
| Xive® MP 5.5 | |
| Keystone | Implant Level |
| PrimaConnex SD 3.3, 3.5 | |
| PrimaConnex RD 4.0, 4.1 | |
| PrimaConnex WD 5.0 | |
| Genesis 3.8, 4.5, 5.5, 6.5 | |
| MIS | Implant Level |
| Internal Hex Narrow SEVEN – M4 | |
| Internal Hex Standard SEVEN – M4 | |
| Internal Hex Wide SEVEN – M4 | |
| Conical Connection Narrow C1 - V3 | |
| Conical Connection Standard C1 - V3 | |
| Conical Connection Wide C1 | |
| Abutment Level | |
| Multi-Unit Abutment | |
| Nobel Biocare | Implant Level |
| NobelActive NP 3.5 | |
| NobelActive RP 4.3, 5.0 | |
| NobelActive WP 5.5 | |
| NobelReplace NP 3.5 | |
| NobelReplace RP 4.3 | |
| NobelReplace WP 5.0 | |
| NobelReplace 6.0 | |
| Branemark System NP 3.3 | |
| Branemark System RP 3.75, 4.0 | |
| Abutment Level | |
| Multi-Unit Abutment RP | |
| Straumann | Implant Level |
| Bone Level 3.3 NC | |
| Bone Level 4.1, 4.8 RC | |
| Standard/Standard Plus 4.8 RN (Regular Neck) | |
| Standard/Standard Plus 4.8 WN (Wide Neck) | |
| Abutment Level | |
| RN Abutment Level | |
| WN Abutment Level | |
| Bone Level Multi-Base Abutment D3.5, 4.5 | |
| Bone Level Multi-Base Angled Abutment | |
| Screw-Retained Abutment 3.5 | |
| Screw-Retained Abutment 4.6 | |
| Zimmer Dental | Implant Level |
| Tapered Screw-Vent™ 3.5, 4.5, 5.7 | |
| Screw Vent™ 3.3, 3.7, 4.5 | |
| Abutment Level | |
| Tapered Abutment |
{3}------------------------------------------------
{4}------------------------------------------------
Type of Use (Select one or both, as applicable)
| X | Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
FORM FDA 3881 (8/14)
PSC Publishing Services (301) 443-6740 вн
{5}------------------------------------------------
Dentsply Sirona 221 West Philadelphia Street Suite 60W York, PA 17401
Image /page/5/Picture/1 description: The image shows the logo for Dentsply Sirona. The logo consists of a stylized, abstract shape on the left, resembling a curved leaf or a stylized letter 'S'. To the right of the shape are the words "Dentsply" on the top line and "Sirona" on the bottom line, with both words in a simple, sans-serif font. The color of the logo and text is a muted gray.
510(k) SUMMARY For K193064 Atlantis® suprastructures
1. Submitter Information:
Dentsply Sirona Inc. 221 West Philadelphia Street Suite 60W York, PA 17401
| Contact Person: | Karl Nittinger |
|---|---|
| Telephone Number: | 717-849-4424 |
| Fax Number: | 717-849-4343 |
| Email: | karl.nittinger@dentsplysirona.com |
Date Prepared: 03 March 2020
2. Device Name:
- Proprietary Name: Atlantis® suprastructures .
- Classification Name: Endosseous dental implant abutment .
- CFR Number: 21 CFR 872.3630
- . Device Class: ●
- Class II Product Code: NHA
3. Predicate Device:
.
Predicate Device for subject Atlantis suprastructures made by milling:
| Predicate Device Name | 510(k) | Company Name |
|---|---|---|
| Multibase Abutments EV and ATLANTIS™Suprastructures | K163350 | Dentsply Sirona |
Predicate Device for subject Atlantis suprastructures made by additive manufacturing:
| Predicate Device Name | 510(k) | Company Name |
|---|---|---|
| ATLANTIS™ Suprastructures | K163398 | Dentsply Sirona |
{6}------------------------------------------------
Reference Devices:
| Reference Device Name | 510(k) | Company Name |
|---|---|---|
| ATLANTIS™ ISUS Implant Suprastructures | K160207 | Dentsply Sirona |
| BioHorizons Tapered Internal Implant System | K071638 | BioHorizons Implant Systems Inc. |
| BioHorizons Simple Solutions with Laser-Lok® | K100985 | BioHorizons Implant Systems, Inc. |
| MIS Internal Hex Dental Implant System | K180282 | MIS Implants Technologies Ltd.(Dentsply Sirona) |
| MIS C1 Narrow Platform Conical ConnectionImplant System, MIS C1 Wide Platform ConicalConnection Abutments | K172505 | MIS Implants Technologies Ltd.(Dentsply Sirona) |
| MIS V3 Conical Connection Dental ImplantSystem | K163349 | MIS Implants Technologies Ltd.(Dentsply Sirona) |
| Conical Connection Implants | K112162 | MIS Implants Technologies Ltd.(Dentsply Sirona) |
| NobelActive Wide Platform (WP) | K133731 | Nobel Biocare AB |
| Various Branemark System Dental ImplantProducts | K022562 | Nobel Biocare AB |
4. Description of Device:
Atlantis suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. The subject Atlantis suprastructures include new compatible interfaces of the currently marketed Atlantis suprastructures made by milling (K163350) or additive manufacturing techniques (K163398) for the following abutments and implants:
- BioHorizons Multi-unit abutment MIS Internal Hex Narrow SEVEN - M4 MIS Internal Hex Standard SEVEN - M4 MIS Internal Hex Wide SEVEN - M4 MIS Conical Connection Narrow C1 - V3 MIS Conical Connection Standard C1 - V3 MIS Conical Connection Wide C1 MIS Multi-Unit Abutment Nobel Biocare NobelActive WP 5.5 Nobel Biocare Branemark System NP 3.3 Nobel Biocare Branemark System RP 3.75, 4.0
The design of the subject device is derived from patient dental models and completed by Dentsply Sirona technicians using computer-assisted design (CAD) according to the clinician's prescription. The final CAD design of the Atlantis suprastructures are fabricated using additive manufacturing (AM) to produce a customized, patient-specific device. The Atlantis suprastructures subject of this bundled premarket notification are fabricated by milling or by additive manufacturing techniques.
{7}------------------------------------------------
The milled Atlantis suprastructures are composed of commercially pure titanium (CPTi) or cobalt chrome alloy and are available in following design types: Bar, Bridge, Hybrid and 2 in 1. Additional design limitations regarding minimum required segment cross-section, maximum span between implants and maximum cantilever extension, have been introduced for Atlantis suprastructures made by milling.
Atlantis suprastructures made by additive manufacturing are provided as Bridge and Hybrid types with optional mechanical retention (pin or cell retention) on the surface. The manufacturing of the Bridges and Hybrids of the Atlantis suprastructures by an additive manufacturing technique start from a titanium alloy and a cobalt-chrome alloy in powder form.
Milled variants of the subject Atlantis® suprastructures are offered in versions composed of unalloyed titanium conforming to ASTM F67 (Standard Specification for Unalloyed Titanium for Surgical Implant Applications) and cobalt chromium alloy (CoCr) conforming to ISO 22674 (Dentistry – Metallic materials for fixed and removable restorations and appliances). Variants of the subject Atlantis® suprastructures which are fabricated utilizing additive manufacturing are manufactured using titanium alloy powder or cobalt chromium alloy powder conforming to ISO 22674 (Dentistrv – Metallic materials for fixed and removable restorations and appliances).
Fixation screws for use with the subject Atlantis® suprastructures are composed of titanium alloy confirming to ASTM F136 (Standard Specification for Wrought Titanium-6 Aluminum-4 Vanadium ELI (Extra Low Interstitial) Alloy for Surgical Implant Applications).
Screws are available for all compatible implants and abutments to screw the Atlantis suprastructures into the implant or onto the abutment.
Labeling is modified by providing a separate compatibility chart which lists all implants and abutments compatible with the Atlantis suprastructures.
న. Indications for Use:
Atlantis® suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring function.
Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants. Atlantis® suprastructures are compatible with the implants and abutments listed in the Atlantis® Suprastructures Compatibility Chart:
{8}------------------------------------------------
| Manufacturer/ | Implant system |
|---|---|
| BioHorizons | Implant Level |
| Internal/ Tapered 3.5, 4.5, 5.7 | |
| Abutment Level | |
| Multi-unit abutment | |
| Biomet 3i | Implant Level |
| Certain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0 | |
| Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5 | |
| Certain™ XP 4/5, 5/6 | |
| Abutment Level | |
| Low Profile Abutment | |
| Camlog | Implant Level |
| Screw-line Implant 3.3 | |
| Screw-line/Root-line Implant 3.8, 4.3 | |
| Screw-line/Root-line Implant 5.0, 6.0 | |
| DentsplySirona | Implant Level |
| Astra Tech Implant System® | |
| Astra Tech Implant EV 3.0 - Green | |
| Astra Tech Implant EV 3.6 - Purple | |
| Astra Tech Implant EV 4.2 - | |
| Yellow Astra Tech Implant EV 4.8 | |
| - Blue Astra Tech Implant EV 5.4 – | |
| Brown Astra Tech Implant EV | |
| Profile 4.2 Astra Tech Implant EV | |
| Profile 4.8 OsseoSpeed® TX 3.0 – | |
| Yellow OsseoSpeed® TX 3.5, 4.0 –Aqua | |
| OsseoSpeed® TX 4.5, 5.0 – Lilac | |
| OsseoSpeed® TX Profile 4.5/5.0 | |
| Xive® | |
| Xive® S 3.0 | |
| Abutment Level | |
| Astra Tech Implant System® | |
| UniAbutment EV | |
| Angled Abutment EV | |
| Multibase Abutment EV | |
| 20° UniAbutment | |
| 45° UniAbutment | |
| Angled Abutment 20° | |
| Ankylos® | |
| Ankylos® Balance Base Narrow D4.2 | |
| Ankylos® Balance Base D5.5 | |
| Xive® | |
| Xive® TG 3.4, 3.8, 4.5 | |
| Xive® MP 3.4, 3.8, 4.5 | |
| Xive® MP 5.5 | |
| Keystone | Implant Level |
| PrimaConnex SD 3.3, 3.5 | |
| PrimaConnex RD 4.0, 4.1 | |
| PrimaConnex WD 5.0 | |
| Genesis 3.8, 4.5, 5.5, 6.5 | |
| MIS | Implant Level |
| Internal Hex Narrow SEVEN – M4 | |
| Internal Hex Standard SEVEN - M4 | |
| Internal Hex Wide SEVEN – M4 | |
| Conical Connection Narrow C1 - V3 | |
| Conical Connection Standard C1 - V3 | |
| Conical Connection Wide C1 | |
| Abutment Level | |
| Multi-Unit Abutment | |
| Nobel Biocare | Implant Level |
| NobelActive NP 3.5 | |
| NobelActive RP 4.3, 5.0 | |
| NobelActive WP 5.5 | |
| NobelReplace NP 3.5 | |
| NobelReplace RP 4.3 | |
| NobelReplace WP 5.0 | |
| NobelReplace 6.0 | |
| Branemark System NP 3.3 | |
| Branemark System RP 3.75, 4.0 | |
| Abutment Level | |
| Multi-Unit Abutment RP | |
| Straumann | Implant Level |
| Bone Level 3.3 NC | |
| Bone Level 4.1, 4.8 RC | |
| Standard/Standard Plus 4.8 RN (Regular Neck) | |
| Standard/Standard Plus 4.8 WN (Wide Neck) | |
| Abutment Level | |
| RN Abutment Level | |
| WN Abutment Level | |
| Bone Level Multi-Base Abutment D3.5, 4.5 | |
| Bone Level Multi-Base Angled Abutment | |
| Screw-Retained Abutment 3.5 | |
| Screw-Retained Abutment 4.6 | |
| Zimmer Dental | Implant Level |
| Tapered Screw-Vent™ 3.5, 4.5, 5.7 | |
| Screw Vent™ 3.3, 3.7, 4.5 | |
| Abutment Level | |
| Tapered Abutment |
{9}------------------------------------------------
Substantial Equivalence: 6.
An overview of the similarities and differences between the subject and predicate devices is given in Table 5.1 and 5.2 below.
The indications for use of the subject and predicate Atlantis suprastructures (K163350, K163398) are identical with respect to the clinical indications. The indications for use of the subject and predicate devices only differ regarding the compatible implants and abutments which are added by this 510(k) premarket notification. Design types, material, manufacturing techniques (milling, additive manufacturing), screw types (standard screw, Angulated Screw Access (ASA) as well as mechanical retention methods on the suprastructure surface (cell, pin) of the subject Atlantis suprastructures are the same as cleared for the predicate Atlantis suprastructures made by milling
{10}------------------------------------------------
(K163350) or additive manufacturing (K163398). The additional design limitations for some design types of milled Atlantis suprastructures (Non-Standard bar, 2 in1 primary structure, Hybrid, Bridge) are within the design parameters cleared for the predicate device (K163350). The design parameters cleared for the predicate Atlantis suprastructures made by additive manufacturing (K163398) remain unchanged for the subject device.
7. Non-Clinical Performance Data:
Following non-clinical test data and analyses are included to support substantial equivalence:
· Cross-sectional material analysis of the subject Atlantis suprastructure interfaces with the compatible implants and abutments, comparison to existing worst case interface geometry and reference to results of fatigue testing (K160207) conducted according to test methods of ISO 14801: Dental-implants Dynamic Fatigue Test for Endosseous Dental Implants. ISO 14801.
· Geometric measurement data and statistical compatibility analysis of OEM implant bodies, OEM abutments, and OEM fixation screws, to support the compatibility of the subject Atlantis suprastructure interfaces with the compatible implants (K071638, K100985, K133731, K022562).
· Reference to process validation testing (K163398) for Atlantis suprastructures made by additive manufacturing.
· Reference by equivalence to validation of moist heat sterilization parameters conducted according to ISO 17665-1 Sterilization of health care products -- Moist heat -- Part 1: Requirements for the development, validation, and routine control of a sterilization process for medical devices and ISO17665-2 Sterilization of health care products - Moist heat - Part 2: Guidance on the application of ISO 17665-1.
· Reference by equivalence to biocompatibility data of predicate devices (K163350, K163398).
8. Clinical Performance Data:
No human clinical data was included in this premarket notification to support the substantial equivalence of the subject Atlantis suprastructures.
9. Conclusion Regarding Substantial Equivalence:
The information included in this bundled 510(k) submission supports the substantial equivalence of the subject Atlantis suprastructures. The subject Atlantis suprastructures have the same intended use as the legally marketed predicate devices cleared under premarket notifications K163350 and K163398. The subject device also has similar indications for use and incorporates the same fundamental technology as the predicate devices (K163398). Results of technical analyses and compatibility studies to verify the performance of the subject Atlantis suprastructures support a determination of substantial equivalence.
{11}------------------------------------------------
| SubjectDevice | Indications for Use | |
|---|---|---|
| DentsplySironaAtlantis®suprastructures | Atlantis® suprastructures are indicated for attachment to dental implants or abutments in thetreatment of partially or totally edentulous jaws for the purpose of restoring chewing function.Atlantis® suprastructures are intended for attachment to a minimum of two (2) implants.The Atlantis® suprastructures are compatible with the implants and abutments listed in theAtlantis® Suprastructures Compatibility Chart: | |
| Manufacturer/Company | Implant system | |
| BioHorizons | Implant LevelInternal/ Tapered 3.5, 4.5, 5.7Abutment LevelMulti-unit abutment | |
| Biomet 3i | Implant LevelCertain™ 3.25, 4.0, 4/3, 5.0, 5/4, 6.0Certain™ Prevail™ 3/4/3 (3.4), 4/5/4, 5/6/5, 4/3, 5/4, 6/5Certain™ XP 4/5, 5/6Abutment LevelLow Profile Abutment | |
| Camlog | Implant LevelScrew-line Implant 3.3Screw-line/Root-line Implant 3.8, 4.3Screw-line/Root-line Implant 5.0, 6.0 | |
| Dentsply Sirona | Implant LevelAstra Tech Implant System®Astra Tech Implant EV 3.0 - GreenAstra Tech Implant EV 3.6 - PurpleAstra Tech Implant EV 4.2 – YellowAstra Tech Implant EV 4.8 – BlueAstra Tech Implant EV 5.4 - BrownAstra Tech Implant EV Profile 4.2Astra Tech Implant EV Profile 4.8OsseoSpeed® TX 3.0 – YellowOsseoSpeed® TX 3.5, 4.0 - AquaOsseoSpeed® TX 4.5, 5.0 - LilacOsseoSpeed® TX Profile 4.5/5.0Xive®Xive® S 3.0Xive® S 3.4, 3.8, 4.5, 5.5Abutment LevelAstra Tech Implant System®UniAbutment EVAngled Abutment EVMultibase Abutment EV20° UniAbutment45° UniAbutmentAngled Abutment 20°Ankylos®Ankylos® Balance Base Narrow D4.2Ankylos® Balance Base D5.5Xive®Xive® TG 3.4, 3.8, 4.5Xive® MP 3.4, 3.8, 4.5Xive® MP 5.5 | |
| SubjectDevice | Indications for Use | |
| Keystone Dental | Implant LevelPrimaConnex SD 3.3, 3.5PrimaConnex RD 4.0, 4.1PrimaConnex WD 5.0Genesis 3.8, 4.5, 5.5, 6.5 | |
| MIS | Implant LevelInternal Hex Narrow SEVEN – M4Internal Hex Standard SEVEN – M4Internal Hex Wide SEVEN – M4Conical Connection Narrow C1 - V3Conical Connection Standard C1 - V3Conical Connection Wide C1Abutment LevelMulti-Unit Abutment | |
| Nobel Biocare | Implant LevelNobelActive NP 3.5NobelActive RP 4.3, 5.0NobelActive WP 5.5NobelReplace NP 3.5NobelReplace RP 4.3NobelReplace WP 5.0NobelReplace 6.0Branemark System NP 3.3Branemark System RP 3.75, 4.0Abutment LevelMulti-Unit Abutment RP | |
| Straumann | Implant LevelBone Level 3.3 NCBone Level 4.1, 4.8 RCStandard/Standard Plus 4.8 RN (Regular Neck)Standard/Standard Plus 4.8 WN (Wide Neck)Abutment LevelRN Abutment LevelWN Abutment LevelBone Level Multi-Base Abutment D3.5, 4.5Bone Level Multi-Base Angled AbutmentScrew-Retained Abutment 3.5Screw-Retained Abutment 4.6 | |
| Zimmer Dental | Implant LevelTapered Screw-Vent™ 3.5, 4.5, 5.7Screw Vent™ 3.3, 3.7, 4.5Abutment LevelTapered Abutment | |
| PredicateDevices | Indications for Use | |
| DentsplySironaMultibaseAbutments EVandATLANTISTMSuprastructuresK163350 | ATLANTIST™ Suprastructures are indicated for attachment to dental implants or abutments in thetreatment of partially or totally edentulous jaws for the purpose of restoring chewing function.ATLANTIST™ Suprastructures are intended for attachment to a minimum of two (2) implants and areindicated for compatibility with the following implant and abutment systems: | |
| Implants: | ||
| Manufacturer | Name of Implant | Size |
| Biomet 3i | Certain | 3.25, 4/3 - Prevail ¾/3, 4/3 |
| Certain | 4.0, 5/4 - Prevail 4/5/4. 5/4 | |
| Certain | 5.0, XP 4/5 - Prevail 5/6/5, 6/5 | |
| Certain | 6.0, XP 5/6 | |
| BioHorizons | Internal/Tapered | 3.5, 4.5, 5.7 |
| Camlog | Screw-line Implant | 3.3 |
| Screw-line / Root-line Implant | 3.8, 4.3, 5.0, 6.0 | |
| XiVE | S 3.0, S 3.4, S 3.8, S 4.5, S 5.5 | |
| DENTSPLYImplants | OsseoSpeed™ TX | 3.0, 3.5/4.0, 4.5/5.0 |
| Osseospeed™ Profile TX | 4.5/5.0 | |
| Osseospeed™ EV | 3.0, 3.6, 4.2, 4.8, 5.4 | |
| Osseospeed™ Profile EV | 4.2, 4.8 | |
| KeystoneDental | PrimaConnex | SD 3.3/3.5 |
| PrimaConnex | RD 4.0/4.1 | |
| PrimaConnex | WD 5.0 | |
| Genesis | 3.8, 4.5, 5.5/6.5 | |
| Nobel Biocare | NobelActive | NP 3.5 - RP 4.3, 5.0 |
| NobelReplace | NP-3.5 - RP 4.3 - WP 5.0 - 6.0 | |
| Straumann | Bone Level | 3.3 NC - 4.1, 4.8 NC |
| Standard Plus | 3.5 NN | |
| Standard / Standard Plus | 4.8 RN - 4.8 WN | |
| ZimmerDental | Tapered Screw Vent / Screw Vent* | Tapered S-V 3.5/S-V 3.3, 3.7 / Tapered S-V 4.5/ S-V 4.5 |
| Tapered Screw Vent | 5.7 | |
| Abutments: | ||
| Manufacturer | Name of Abutment | |
| Biomet 3i | Low Profile Abutment | |
| DENTSPLY | ATIS Uni Abutment EV | |
| ATIS UniAbutment 20°, ATIS Un | ||
| ATIS Angled Abutment EV | ||
| ATIS Angled Abutment 20° | ||
| ANKYLOS Balance Base Narrow D4.2, Balance Base D5.5 | ||
| ATIS Multibase Abutment EV | ||
| XiVE MP 3.4, MP 3.8, MP 4.5, MP 5.5 | ||
| XiVE TG 3.4, TG 3.8, TG 4.5 | ||
| Nobel Biocare | Multi-Unit Abutment RP | |
| Straumann | Bone Level Multi-Base Angled AbutmentBone Level Multi-Base Abutment D3.5, D4.5 | |
| RN Abutment Level, WN Abutment LevelScrew-Retained Abutment 3.5, 4.6 | ||
| ZimmerDental | Tapered Abutment |
Table 5.1: Indications for Use for the subject and the predicate devices
{12}------------------------------------------------
Table 5.1: Indications for Use for the subject and the predicate devices (cont.)
{13}------------------------------------------------
Table 5.1: Indications for Use for the subject and the predicate devices (cont.)
{14}------------------------------------------------
| Table 5.1: Indications for Use for the subject and the predicate devices (cont.) | |||
|---|---|---|---|
| PredicateDevices | Indications for Use |
|---|---|
| DentsplySirona | ATLANTIS suprastructures are indicated for attachment to dental implants or abutments in the treatment of partially or totally edentulous jaws for the purpose of restoring chewing function. |
| ATLANTISTMSuprastructuresK163398 | ATLANTIS suprastructures are intended for attachment to a minimum of two (2) implants and are indicated for compatibility with the following implant and abutment systems:Implants: Biomet 3i Certain 3.25, 4/3 - Prevail 3/4/3, 4/3 Biomet 3i Certain 4.0, 5/4 - Prevail 4/5/4, 5/4 Biomet 3i Certain 5.0,XP4/5 - Prevail 5/6/5, 6/5 Biomet 3i Certain 6.0, XP 5/6 BioHorizons Internal/Tapered 3.5, 4.5, 5.7 Camlog Screw-line Implant 3.3 Camlog Screw-line / Root-line Implant 3.8, 4.3, 5.0, 6.0 DENTSPLY Implants XiVE S 3.0, S 3.4, S 3.8, S 4.5, S 5.5 DENTSPLY Implants OsseoSpeed TX 3.0, 3.5/4.0, 4.5/5.0 DENTSPLY Implants OsseoSpeed Profile TX 4.5, 5.0 DENTSPLY Implants OsseoSpeed EV 3.0, 3.6, 4.2, 4.8, 5,4 DENTSPLY Implants OsseoSpeed Profile EV 4.2, 4.8 Keystone Dental PrimaConnex SD 3.3, 3.5 Keystone Dental PrimaConnex RD 4.0, 4.1 Keystone Dental PrimaConnex WD 5.0 Keystone Dental Genesis 3.8, 4.5, 5.5/6.5 Nobel Biocare NobelActive NP 3.5 - RP 4.3, 5.0 Nobel Biocare NobelReplace NP 3.5 - RP 4.3 - WP 5.0 - 6.0 Straumann Bone Level 3.3 NC - 4.1, 4.8 RC Straumann Standard Plus 3.5 NN Straumann Standard/Standard Plus 4.8 RN - 4.8 WN Zimmer Dental Tapered S-V 3.5/ S-V 3.3, 3.7 /Tapered S-V 4.5/ S-V 4.5 Zimmer Dental Tapered Screw-Vent 5.7 Abutments: Biomet 3i Low Profile Abutment DENTSPLY Implants ATIS Uni Abutment EV DENTSPLY Implants ATIS UniAbutment 20°, ATIS UniAbutment 45° DENTSPLY Implants ATIS Angled Abutment EV,ATIS Angled Abutment 20° DENTSPLY Implants Ankylos Balance Base Narrow D4.2,Balance Base D5.5 DENTSPLY Implants XiVE MP 3.4, MP 3.8, MP 4.5, MP 5.5 DENTSPLY Implants XiVE TG 3.4, TG 3.8, TG 4.5 Nobel Biocare Multi-Unit Abutment RP Straumann Bone Level Multi-Base Angled Abutment Straumann Bone Level Multi-Base Abutment D3.5, D4.5 Straumann RN Abutment Level, WN Abutment Level Straumann Screw-Retained Abutment 3.5 Straumann Screw-Retained Abutment 4.6 Zimmer Dental Tapered Abutment |
{15}------------------------------------------------
| Subject device | Predicate Devices | ||
|---|---|---|---|
| Dentsply SironaAtlantis® suprastructures | Dentsply SironaMultibase Abutments EV andATLANTIS™ SuprastructuresK163350 | Dentsply SironaATLANTIS™ SuprastructuresK163398 | |
| Design | |||
| Restoration | multi-unit | multi-unit | multi-unit |
| Design type | Bar, Bridge, Hybrid, 2 in 1 | Bar, Bridge, Hybrid, 2 in 1 | Bridge, Hybrid |
| Prosthesis attachment | screw-retained, friction fit (2in1) | screw-retained, friction fit (2in1) | screw-retained, friction fit (2in1) |
| Connection suprastructure - implant/abutment | internal, external | internal, external | internal, external |
| Design Technology | CAD/CAM (Milling, AdditiveManufacturing (AM)) | CAD/CAM (Milling) | CAD/CAM (AdditiveManufacturing) (AM) |
| Design parameters Standard Bar Micro/ StandardBar Macro | $20 mm$ / $40 mm$$6 mm$ / $8 mm$$2,5 mm2$ / $4.98 mm2$ | $20 mm$ / $40 mm$$6 mm$ / $8 mm$$2,5 mm2$ / $4.98 mm2$ | N/A |
| Design parameters Non-Standard bar, 2 in1primary structure, Hybrid (milled), Bridge(milled): | $40 mm$$15 mm$$2.5 mm2$ / $4.98 mm2$ /$4.0 mm$ height, $3.0 mm$ width* | $40 mm$$15 mm$$4.0 mm$ height, $3.0 mm$ width | N/A |
| Design parameters Bridge and Hybrid (AM) | $40 mm$$15 mm$$4.0 mm$ height, $3.0 mm$ width | N/A | $40 mm$$15 mm$$4.0 mm$ height, $3.0 mm$ width |
| Subject device | Predicate Devices | ||
| Dentsply SironaAtlantis® suprastructures | Dentsply SironaMultibase Abutments andATLANTIS™ SuprastructuresK163350 | Dentsply SironaATLANTIS™ SuprastructuresK163398 | |
| Mechanical retention | no retentionCell or pin retention (optional for AM) | no retention | Cell or pin retention (optional) |
| Screws | Standard screwsAngulated Screw Access (ASA)screws | Standard screwsAngulated Screw Access (ASA)screws | Standard screwsAngulated Screw Access (ASA)screws |
| Material | |||
| Abutment/ suprastructure | Commercially pure titanium (block)Titanium alloy (powder)Cobalt-chrome alloy (block, powder) | Commercially pure titanium (block)Titanium alloy (powder)Cobalt-chrome alloy (block, powder) | Commercially pure titanium (block)Titanium alloy (powder)Cobalt-chrome alloy (block, powder) |
| Prosthetic screw | Titanium alloy block | Titanium alloy block | Titanium alloy block |
Table 5.2: Similarities and Differences between the subject and the predicate devices
*2.5 mm²: if span between implants 0 to 20 mm or cantilever 0 to 6 mm²: if span between implants >20 to 40 mm or cantilever >6 to 8 mm), 4.0 mm height, 3.0 mm width: if cantilever >8 to 15 mm
{16}------------------------------------------------
Table 5.2: Similarities and Differences between the subject and the predicate devices (cont.)
§ 872.3630 Endosseous dental implant abutment.
(a)
Identification. An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)